Extremely Effective RA Medicine Raises Chances of Lymphoma

In April, 2008, Cizma was approved for treatment against moderate to severe Crohn's Disease in patients who had tried other methods, but found no relief. It has also been preliminarily approved for use in the treatment to moderate to severe Rheumatoid Arthritis or RA.

RA effects more than 2 million Americans. Seventy-five percent of those ill with RA are women, and for years, doctors and chemists have been devising medications that can, not only stop the progression of the disease, but also treat the symptoms so that life for RA survivors can be more productive. The American public has now grown accustomed to seeing television advertisements for drugs like, Humira - which is in the same class as Cizmia. The difference between Cizmia and the other drugs in its family, is that Cizmia claims what the others cannot: That their drug can treat the symptoms of RA without causing any of the usual injection site reactions. (Cizmia, like many other RA drugs, is an injectable).

In a six month study, 400 mg of Cizmia was given to RA patients every four weeks, and their symptoms and pain were significantly reduced by the drug. Many with RA are demanding its immediate and full release to the US public. However, Cizmia cannot claim complete safety. As with all drugs of this class, there are risks, and Cizmia's, one could easily argue, far out shadow its treatments benefits.

Some people who have taken Cizmia have become ill with a certain form of cancer called Lymphoma - or cancer of the lymphnodes. This is one of the deadliest forms of cancer on earth today. If caught too late, it is incurable and often the signs are unnoticeable for sometime while the cancer grows. Because Cizmia works as an immune suppressant to squash the overactive nature of autoimmune activity inside the joints, Cizmia can also leave its patient at high risk for an infection. Labels on the drug warn users to speak with their doctors even if they have a simple cut on the hand, a common cold, or especially something much more serious like Tuberculosis. Cizmia can also increase or cause new heart failure, nervous system disorders - like those seen in multiple sclerosis, and it can cause serious allergic reactions. It is not made of a substance the body is used to receiving sudden, large doses of.

While Cizmia appears to offer much hope to those victims of Rheumatoid Arthritis, it must also be noted that its risks may outweigh its benefits. Every patient should seek their doctor's advice when requesting a script for a new medication or when beginning a new medicinal regimen.